An Independent Review? Spotlight on the Cochrane Collaboration

The Cochrane Collaboration is a prestigious, well-respected non-profit organization that reviews systematic reviews of research in health care and health policy. With a journal impact factor of 9.26, the Cochrane Database of Systematic Reviews (CDSR) is placed 11th out of 169 journals in the Medicine, General, and Internal categories. TrialSite recently reported on the potential for bias on Cochrane’s Ivermectin Analysis. Two well-respected German microbiologists recently informed TrialSite's editorial board that the WHO and European EMA's opposition to the use of ivermectin for COVID-19 therapy is based in part on inaccurate Cochrane assessments. Here, TrialSite looks to the names behind the Cochrane reports and connections they have with government or industries that could lead to a conflict of interest.

Cochrane Board’s Members Reduced

Following a contentious vote to expel a member for the first time in the Cochrane Collaboration's 25-year history, the board of the Cochrane Collaboration was reduced from 13 to 6 members in September 2018. The action is being taken in response to "numerous complaints" regarding a member following the release early 2018 of a critique he co-...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee